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Abstract 
Acute tumor lysis syndrome (TLS) is a condition resulting from rapid destruction of tumor 
cells and subsequent massive release of cellular breakdown products. It has been 
described following the treatment of many hematologic and solid malignancies. 
However, spontaneous TLS has rarely been described. Here we report a case of 
spontaneous TLS that occurred in a patient with a treated maxillary squamous cell 
carcinoma (SCC) presenting with diffuse liver metastases, which is an infrequent site of 
distant metastases. 
 
Introduction 
Acute tumor lysis syndrome (TLS) is a constellation of metabolic disturbances that can 
develop in rapidly proliferating tumors, mainly hematologic malignancies, or more rarely 
in solid tumors after initiation of cytotoxic therapy. It is characterized by the release of 
large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. 
This can lead to hyperuricemia, hyperphosphatemia, hyperkalemia and hypocalcemia, 
which can cause lactic acidosis, acute renal failure, cardiac arrhythmias, seizures, muscle 
cramps, tetany, syncope, and possibly sudden death. TLS has been reported to occur in 
very few cases of solid tumors without any prior therapy. Here we report an unusual case 
of a maxillary squamous cell carcinoma (SCC) who presented a few months after 
treatment of the primary disease with diffuse liver metastases and TLS.  
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Case Report 
The patient is a 53-year-old man who started to complain of progressive left cheek pain, nasal 
obstruction and epistaxis. CT scan of the head and neck showed a left maxillary sinus mass invading the 
medial and anterior walls of the sinus, extending into the left nasal cavity and soft tissues of the cheek 
and eroding the floor of the orbit. MRI of the sinuses confirmed these findings. Biopsy from the tumor 
revealed infiltrating squamous cell carcinoma arising from an inverted papilloma with focal high-grade 
dysplasia. Chest CT scan and abdominal ultrasound were negative for metastases. The patient 
underwent a radical maxillectomy that showed infiltrating squamous cell carcinoma of 2.8 × 2 × 2 cm 
originating from an inverted papilloma with presence of vascular and perineural invasion and negative 
margins of resection. After surgery, the patient received adjuvant chemoradiation of 66 Gy to the tumor 
bed and 50 Gy to the upper neck area. At the end of treatment, the patient started to complain of 
crampy abdominal pain. Abdominal ultrasound was requested and revealed multiple hypoechoic liver 
nodules that are suspicious for metastases (fig. 1). 
CT-guided core biopsy of one of these lesions was performed and showed high-grade carcinoma 
with focal positivity for CK8/18 and no staining for high-molecular-weight cytokeratin, compatible with 
a metastatic poorly differentiated carcinoma similar to the previous pathology. Four days later, the 
patient presented to the emergency room with a decrease in the level of consciousness and abdominal 
pain. Laboratory investigations revealed a BUN of 144 mg/dl; creatinine, 6.4 mg/dl; uric acid, 20.9 
mg/dl; potassium, 7.6 mg/dl; phosphorus, 11.8 mg/dl; calcium, 6.2 mg/dl; ALP, 734 IU/L; GGT, 621 
IU/l; and lactate dehydrogenase (LDH), 1,000 U/l (table 1). An ultrasound of the abdomen showed 
normal kidneys. The clinical picture and the rapidly progressive disease, the acute deterioration in 
electrolytes, and kidney function are all in favor of an acute TLS. The patient was treated with 
allopurinol, urinary alkalinization, and rehydration. He was also given one dose of rasburicase 8 mg, but 
he deteriorated rapidly and passed away the following day from TLS. 
Discussion 
TLS is characterized by hyperphosphatemia, hyperuricemia, hyperkalemia, 
hypocalcemia, lactic acidosis, and acute renal failure. Hyperuricemia is the result of 
purine degradation and may lead to precipitation of uric acid crystals in the collecting 
tubules in the kidney, resulting in obstructive nephropathy. Hyperkalemia is due to 
potassium release from the cytoplasm and may lead to cardiac arrhythmias and cardiac 
arrest. Hyperphosphatemia, caused by nucleoprotein degradation, may cause 
precipitation of calcium phosphate in the renal tubules. Hypocalcemia follows the 
precipitation of calcium phosphate in the tissues and may cause neurologic and muscular 
symptoms.  
Patients at highest risk for acute TLS are those who have a large tumor burden or 
rapidly proliferating tumors, mainly hematologic malignancies, such as leukemia and 
lymphoma [1]. Acute TLS is a metabolic complication of chemotherapy: cytotoxic 
therapy can induce cytolysis of neoplastic cells and release of intracellular substances, 
which can precipitate this syndrome. It is more rarely seen in solid tumors, and it has 
been reported to occur after therapy. A review of the literature by Kalemkerian et al. [2] 
found 25 cases of patients with solid tumors who developed acute TLS after treatment. 
TLS has been described in association with a variety of solid tumors. These tumors are 
usually bulky with multiple metastatic sites, and acute TLS was described to develop after 
recent treatment. 
Only a few cases of spontaneous TLS in solid tumors have been described without any 
prior therapy (table 2) [4–11]. In this case, acute TLS may be due to cell turnover rather 
than to a treatment effect. 
Crittenden and Ackerman [3] were the first to report a case of disseminated 
adenocarcinoma of the gastrointestinal tract with renal failure and high levels of uric acid.  
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We reported the first case of TLS secondary to liver metastases from a primary maxillary 
SCC.  
On the other hand, the liver is a very rare location of metastases from maxillary sinus 
tumors. The incidence of lymphadenopathy at diagnosis is very low because the maxillary 
sinuses have a limited lymphatic supply [12]. Regional and distant metastasis are also 
uncommon in this disease entity [13]. Dulguerov et al. reviewed 220 patients who were 
treated for nasal and paranasal sinus carcinoma between 1975 and 1994 with a minimum 
follow-up of 4 years and found that only 9 patients (4.3%) developed distant metastasis 
[14]. 
In a recent study published by Tanvetyanon et al. [15], the medical records of patients 
with inverted papilloma (IP) and SCC treated during 1999–2007 were retrospectively 
reviewed. Four biopsy specimens were described as SCC arising in IP, one case was read 
as carcinoma in situ arising in IP and one as IP with areas of severe dysplasia. Liver 
metastases were described in one case and were discovered at the time of local recurrence 
along with lung metastases 33 months after diagnosis. 
In conclusion, our case is unique in so far as the patient developed liver metastases, 
which is a rare location for distant metastases from maxillary tumors, even without 
developing local or locoregional recurrence, and in the development of spontaneous TLS, 
which is an unusual finding in solid tumors and was never reported in sinus SCC. 
Spontaneous TLS should be anticipated in solid tumors with a large volume of metastatic 
disease. 
 
 
 
Table 1. Development of the laboratory blood results of the patient until his death 
  2 weeks prior  
to presentation 
Day 1  Day 2  Day 3 
BUN, mg/dl    144  98  129 
Creatinine, mg/dl  0.5  6.4  4  5.1 
Potassium, mmol/l    7.6  4.7  5.6 
Calcium, mg/dl    10.7  6.2  8.9 
Phosphate, mg/dl    11.8  7.8  13.2 
Carbon dioxide, mmol/l    15  11  13 
Uric acid, mg/dl        20.9 
ALP, IU/l  375  734     
GGT, IU/l  594  621     
Bilirubin (total/direct), mg/dl  0.7/0.5      1/0.8 
LDH, IU/l  271  1,000     
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Table 2. Reported cases of spontaneous TLS in solid tumors 
 Metastases  Metastatic  sites  Outcome 
Gastrointestinal adenocarcinoma [3]  Yes  Liver/bone  Death 
Colon cancer [4]  Yes  Liver/bone  Improvement 
Pheochromocytoma [4]  No    Improvement 
Hepatocellular carcinoma [4]  No    Death 
Germinoma [5]  Yes  Liver/lungs/ 
paraaortic lymph nodes 
Improvement 
Germinoma [5]  Yes  paraaortic lymph nodes  Improvement 
Breast cancer [6]  Yes  Liver/lungs/bone  
lymphangitic spread 
Death after recurrence 
of TLS 
Prostate cancer [7]  Yes  Liver/bone  Death 
Gastric cancer [8]  Yes  Liver/lymph nodes  Improvement then 
death from pneumonia 
Non-small cell lung cancer [9]  Yes  Liver  Death 
Non-small cell lung cancer [10]  No    Improvement 
Non-hodgkin lymphoma [11]  No    Death 
Retroperitoneal non-hodgkin  
lymphoma [11] 
No   Improvement 
Currently reported case  Yes  Liver  Death 
 
 
 
 
Fig. 1. Abdominal CT scan showing diffuse liver metastases. 
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